Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Asthma-I: Introduction01:29

Asthma-I: Introduction

2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

502
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
502
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

336
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
336

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

The Lancet. Respiratory medicine·2026
Same author

From mild-to-moderate to severe asthma: Risk factors and patient profiles from the NORDSTAR cohort.

American journal of respiratory and critical care medicine·2026
Same author

Never say die: making a death from asthma a never event.

Thorax·2026
Same author

Azithromycin enhances epithelial antiviral immunity in uncontrolled asthma: results from the AZIMUNE randomized controlled trial.

The European respiratory journal·2026
Same author

The 2024 UK asthma guidelines: considerations for patients with asthma not responding to maintenance and reliever therapy.

The British journal of general practice : the journal of the Royal College of General Practitioners·2026
Same author

A systemic concern with arterial blood gas analysers in patients with increased temperatures that has the potential to adversely impact on patient care: an observational study.

Emergency medicine journal : EMJ·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Aug 13, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K

喘息について

Celeste Porsbjerg1, Erik Melén2, Lauri Lehtimäki3

  • 1Department of Respiratory and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Lancet (London, England)
|January 22, 2023
PubMed
まとめ
この要約は機械生成です。

喘息は世界中で何百万人もの人に 影響する一般的な呼吸器疾患です 治療法は改善されていますが 治療法を調整する際の理解は 喘息のコントロールと重症症例の管理の鍵です

さらに関連する動画

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.4K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.1K

関連する実験動画

Last Updated: Aug 13, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.4K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.1K

科学分野:

  • 肺病と呼吸器医学
  • 臨床医学

背景:

  • 喘息は慢性非伝染性呼吸器疾患で 世界中で蔓延しています
  • 呼吸不全や喘息のような症状を 引き起こします
  • 過去15年間,治療法における重要な進歩により 喘息の罹患率と死亡率が改善されました.

研究 の 目的:

  • 臨床的に集中した 喘息の概要を提供するためです
  • 疫学,病理生理学,診断,および子供と成人の両方の管理をカバーする.
  • 重度の喘息の治療における 精密医療と疾患寛解への移行を強調する.

主な方法:

  • 喘息に関する最新の臨床文献とガイドラインのレビュー
  • 疫学的傾向と病理学的メカニズムに関する情報の統合
  • 生物学的治療を含む診断方法と現在の管理戦略の議論

主要な成果:

  • ほとんどの患者は,利用可能な治療法で良い喘息のコントロールを達成できます.
  • 治療の不足は依然として課題であり,治療の調整をよりよく理解する必要性を強調しています.
  • 重度の喘息の治療は 精密医療によって進行しており 病気の寛解を目指しています

結論:

  • 効果的な喘息管理には,周期的な評価と治療の調整が必要です.
  • 重度の喘息の併存は多面的な管理戦略を必要とします.
  • 患者と医療従事者の継続的な教育は 喘息のケアを最適化するために不可欠です